THERAPEUTIC COMPOSITION FOR INTERSTITIAL PHEUMONIA

摘要

Disclosed is a therapeutic agent for interstitial pneumonia, which ensure s to exert the effect of superoxide dismutase (SOD) contained therein. Speci fically disclosed is a therapeutic agent for interstitial pneumonia, which c omprises 10 to 100 mg of lecithin-conjugated superoxide dismutase represente d by the general formula (I), which further comprises sucrose for the purpos e of increasing its stability, and which has a dosage form suitable for intr avenous administration. SOD'(Q-B)m (I) wherein SOD' represents a residue of superoxide dismutase; Q represents a chemical crosslink; B represents a resi due produced by removing a hydrogen atom from a hydroxy group in lysolecithi n which has the hydroxy group at position-2 of a glycerol moiety therein; an d m represents an average number of lysolecithin molecules bound to one supe roxide dismutase molecule and is an integer of 1 or greater.